Merck (MRK) is among those interested in Inhibrx's (INBX) experimental cancer drug, Reuters reports citing source
This development indicates that Merck's interest in Inhibrx's experimental cancer drug could lead to potential strategic collaboration or acquisition, which may enhance Merck's oncology portfolio.
EU's EUR 90bln Ukraine loan to move ahead after Hungary lifts block, according to Bloomberg
Best Buy (BBY) says Jason Bonfig is to succeed Corie Barry as CEO
Merck (MRK) is among those interested in Inhibrx's (INBX) experimental cancer drug, Reuters reports citing source
Turkish CBRT Policy Announcement (Apr) 37% (exp. 37%, prev. 37%)
Moody's (MCO) Q1 2026 (USD): EPS 4.33 (exp. 4.24), Revenue 2.08bln (exp. 2.07bln)
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
Such moves can signal confidence in Inhibrx's technology and could impact valuations for both companies, as well as spark interest across the pharmaceutical sector in related assets.
Related headlines
- Merck (MRK) veteran and psychedelics developer tapped for top FDA job16 hours ago
- Newsquawk Daily European Equity Opening News - 9th September 20266 hours ago
- European Equity pre-Market Summary - 9th September 2026: European bourses are indicative of a slightly softer open; Inditex reports poor results6 hours ago
- US Market Wrap: Stocks fall and crude gains amid escalating geopolitics 15 hours ago
- European Movers: Airbus (AIR FP) -1.3%, LVMH (MC FP) -1.3%, Orsted (ORSTED DC) -1.6%, Inditex (ITX SM) -3%, Burberry (BRBY LN) -3%5 hours ago
- Newsquawk Daily Asia-Pac Opening News - 9th September 202614 hours ago
- Sam Altman privately told a group of GOP economists he does NOT support having the government own shares in OpenAI, reports Washington Sun33 min ago
- Dow (DOW) reportedly weighs exit from USD 20bln Saudi chemicals venture34 min ago
- Amazon (AMZN) plans to issue multiple series of sterling-denominated notes44 min ago
- Baker Hughes (BKR) guides FY26 revenue USD 28.5-30.3bln (prev. USD 26.7-28.1bln) and adj. EBITDA USD 4.9-5.5bln (prev. USD 4.6-5.1bln), according to SEC filing1 hour ago
- Sysco (SYY) reaffirms its FY27 guidance and raises its mid-term targets2 hours ago
- Google (GOOG) is to invest a minimum of EUR 13bln in Finland’s AI infrastructure in 2027-28, according to Finnish broadcaster YLE5 hours ago
- US Department of Justice plans closer scrutiny of Fox's (FOXA) USD 22bln Roku (ROKU) deal, according to Semafor13 hours ago
- Broadcom (AVGO) CEO says co. can lock in chip supply for 2027 and it is in the process of locking in 2028 supply 16 hours ago
- OpenAI is launching ChatGPT Images 2.5 on Tuesday, Axios reports17 hours ago
- OpenAI CFO says enterprise business has been "on a tear", CNBC reports18 hours ago
- FDA notes FI recalls dog supplements due to possible salmonella contamination18 hours ago
- Google (GOOGL) says Gemini is seeing strong adoption across both large enterprises and small and medium-sized businesses, supporting broader commercial traction for Alphabet's AI platform18 hours ago
- Pentagon has decided on the maker of the US navy's next-generation stealth fighter, according to reports; US navy next-generation stealth fighter manufacturer announcement to come within weeks19 hours ago
- Newsquawk Daily US Earnings Estimates: 9th September 2026 - COO20 hours ago
The whole workspace, free to try.
Try it free